Animal models of neonatal stroke

Current Opinion in Pediatrics

Volumn 13, Issue 6, 2001, Pages 506-516

  Ashwal, S ^a   Pearce, W J ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FIBRINOLYTIC AGENT; FREE RADICAL; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; IRON CHELATING AGENT; MAGNESIUM SULFATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CAROTID ARTERY OBSTRUCTION; ENZYME ACTIVITY; FIBRINOLYTIC THERAPY; INDUCED HYPOTHERMIA; INFLAMMATION; IRON METABOLISM; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEWBORN DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK FACTOR; STROKE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA, BRAIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; NITRIC OXIDE; TRANSCRIPTION FACTORS;

EID: 0035675198     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200112000-00003     Document Type: Review

References (110)

1. Unilateral neonatal cerebral infarction in full term infants
2. Cerebral infarction as multifocal clonic seizures in a term neonate
3. Neonatal stroke in the United States: Results of the National Hospital Discharge Survey, 1980-1998
4. Neonatal stroke: Clinical characteristics and cerebral blood flow velocity measurements
5. Term early-onset neonatal seizures: Obstetric characteristics, etiologic classifications, and perinatal care
6. Neonatal stroke: Description of patients and investigation into pathogenesis
7. An unusual cause of neonatal seizures in a newborn infant
8. Brain ischemic lesions of the newborn
9. Results of parenchymal and angiographic magnetic resonance imaging and neuropsychological testing of children after stroke as neonates
10. Diffusion-weighted imaging in neonatal cerebral infarction: Clinical utility and follow-up
11. Neonatal cerebral infarction
12. Early prognostic indicators of outcome in infants with neonatal cerebral infarction: A clinical, electroencephalogram, and magnetic resonance imaging study
13. Fetal and neonatal cerebral infarcts
14. Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors
15. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children
16. Timing and etiology and neonatal cerebral infarction
17. Outcome of neonatal strokes
18. Cerebral infarction in the term newborn: Clinical presentation and long-term outcome
19. Perinatal cortical infarction within middle cerebral artery trunks
20. Ischemic cell death in brain neurons
21. Biochemical and molecular characteristics of the brain with developing cerebral infarction
22. Perinatal brain injury
23. Novel treatments after experimental brain injury
24. Update on perinatal hypoxic insult: Mechanism, diagnosis and interventions
25. Mechanisms of perinatal brain injury
26. Functional differentiation of multiple perilesional zones after focal cerebral ischemia
27. Inflammatory mediators and neonatal brain damage
28. Some animal models for the study of perinatal asphyxia
29. A new model of neonatal stroke: Reversible middle cerebral artery occlusion in the rat pup
30. The influence of immaturity on hypoxia-ischemic brain damage in the rat
31. Animal models for the study of perinatal hypoxic-ischemic encephalopathy: A critical analysis
32. A model of perinatal hypoxic-ischemic brain damage
33. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?
34. Hypoxia-ischemia model in the 7-day-old rat: Possibilities and shortcomings
35. Neonatal reversible focal cerebral ischemia: A new model
36. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup
37. Cognitive deficits after focal cerebral ischemia in mice
38. Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat
39. Long-lasting behavioral alterations following a hypoxic/ischemic brain injury in neonatal rats
40. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion in the rat pup
41. Evolution of brain injury after transient middle cerebral artery occlusion in neonatal rats
42. Delayed cell death in neonatal mouse hippocampus from hypoxia-ischemia is neither apoptotic nor necrotic
43. Repetitive intermittent hypoxia-ischemia and brain damage in neonatal rats
44. Chronic ischemia preferentially causes white matter injury in the neonatal rat brain
45. Role of excitatory amino acid transporter 1 in neonatal rat neuronal damage induced by hypoxia-ischemia
46. Expression of induced nitric oxide synthase in amoeboid microglia in postnatal rats following an exposure to hypoxia
47. Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains
48. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat
49. Hypoxic-ischemic tolerance induced by hyperthermic pretreatment in newborn rats
50. Serial magnetic resonance diffusion and hemodynamic imaging in a neonatal rabbit model of hypoxic-ischemic encephalopathy
51. Metabolite changes in neonatal rat brain during and after cerebral hypoxia-ischemia: A magnetic resonance spectroscopic imaging study
52. 99mTc annexin V imaging of neonatal hypoxic brain injury
53. Continuous monitoring of fetal pH, pO(2) and pCO(2) using a fiberoptic multiparameter sensor in animal models reproducing in utero conditions
54. The influence of variations in blood flow on pulsed Doppler ultrasonic heating of the cerebral cortex of the neonatal pig
55. Continuous observation of nitric oxide production in the fetal rat brain during ischemia
56. Brain perfusion monitoring with frequency-domain and continuous-wave near-infrared spectroscopy: A cross-correlation study in newborn piglets
57. Hypoxia-induced generation of nitric oxide free radicals in cerebral cortex of newborn guinea pigs
58. Cerebral Ischemia: From animal studies to clinical practice. Should the methods be reviewed?
59. Current status and perspectives of neuroprotection in ischemic stroke treatment
60. Cell death in neonatal hypoxia-ischemia
61. Impaired cerebral autoregulation 24 hours after induction of transient unilateral focal ischemia in the rat
62. N-methyl-D-aspartate but not glutamate induces the release of hydroxyl radicals in the neonatal rat: Modulation by group 2 metabotropic glutamate receptors
63. Lessons learned from nitric oxide synthase knockout animals
64. Effects of nitric oxide on neuronal and cerebrovascular function
65. Differing effects of copper, zinc superoxide dismutase overexpression on neurotoxicity elicited by nitric oxide, reactive oxygen species, and excitotoxins
66. Reduced nitric oxide is involved in prenatal ischemia-induced tolerance to neonatal hypoxic-ischemic brain injury in rats
67. Delayed increase in neuronal nitric oxide synthase immunoreactivity in thalamus and other brain regions after hypoxic-ischemic injury in neonatal rats
68. Nitric oxide synthase activity and inhibition after neonatal hypoxia ischemia in the mouse brain
69. Immature brain injury via peroxynitrite production induced by inducible nitric oxide synthase after hypoxia-ischemia in rats
70. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat
71. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain
72. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat
73. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain
74. Inhibition of TNF-α can attenuate or exacerbate excitotoxic injury in neonatal rat brain
75. Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme
76. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: Lack of long-term protection
77. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats
78. HIF-I: Mediator of physiologic and pathophysiologic responses to hypoxia
79. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain
80. Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain
81. Multiple molecular penumbras after focal cerebral ischemia
82. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells
83. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain
84. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia
85. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: A mechanism of "pathologic apoptosis?"
86. Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia
87. NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia
88. Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: Relation to activation of caspase-3 and neuronal injury
89. Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats
90. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is unregulated following cerebral hypoxic-ischemic injury to the developing rat brain
91. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis
92. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis
93. N-tosyl-L-phenylalanyl-chloromethylketone reduces hypoxic-ischemic brain injury in rat pups
94. The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells
95. Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice
96. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia
97. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway
98. Hypoxic-ischemic brain damage in immature rats: Effects of adrenoceptor modulation
99. Mechanisms of perinatal cerebral injury in fetus and newborn
100. Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn
101. Systematic review of therapy after hypoxic-ischemic brain injury in the perinatal period
102. Cerebral hypothermia for prevention of brain injury following perinatal asphyxia
103. Cooling the newborn after asphyxia - Physiologic and experimental background and its clinical use
104. Effects of delayed intraischemic and postischemic hypothermia on a focal model of transient cerebral ischemia in rats
105. Immunohistochemical expression of Bcl-2, Bax and cytochrome c following focal cerebral ischemia and effect of hypothermia in rat
106. Resuscitative hypothermia protects the neonatal rat brain from hypoxic-ischemic injury
107. Influence of mild hypothermia on delayed mitochondrial dysfunction after transient intrauterine ischemia in the immature rat brain
108. Cerebral palsy and experimental hypoxia-induced perinatal brain injury: Is magnesium protective?
109. Survival and histologic evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat
110. Long-term magnesium sulfate treatment as protection against hypoxic-ischemic brain injury in seven-day-old rats